Every SEC Form 3/4/5 on record for this filer (CIK 1236389) — 7 issuers, 149 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| DXCM | DEXCOM INC | Director | 2016-05-26 → 2026-06-17 | 37 | −$6M |
| AMN | AMN HEALTHCARE SERVICES INC | Director | 2016-12-16 → 2026-06-17 | 21 | −$1M |
| ENTA | ENANTA PHARMACEUTICALS INC | Director | 2020-07-01 → 2026-03-13 | 8 | — |
| TOCA | Tocagen Inc | EVP & Chief Financial Officer · lapsed | 2017-04-12 → 2019-10-04 | 8 | $71,500 |
| RGLS | Regulus Therapeutics Inc. | Director · lapsed | 2015-08-13 → 2017-12-06 | 4 | $76,400 |
| AHS | AMN HEALTHCARE SERVICES INC | Director · lapsed | 2016-04-22 → 2016-04-22 | 1 | — |
| BIOC | BIOCEPT INC | Interim CFO · lapsed | 2015-08-20 → 2015-09-02 | 2 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| AMN | 2026-06-15 | Sell | 2,000 | $31.07 | $62,140 | 17,917 |
| AMN | 2026-06-15 | Sell | 1,681 | $31.07 | $52,229 | 19,917 |
| DXCM | 2026-06-15 | Sell | 3,801 | $74.10 | $281,654 | 53,051 |
| DXCM | 2026-06-15 | Sell | 199 | $74.82 | $14,889 | 52,852 |
| DXCM | 2025-08-15 | Sell | 2,555 | $81.02 | $207,006 | 51,316 |
| DXCM | 2025-08-15 | Sell | 195 | $81.54 | $15,900 | 51,121 |
3 of 7 issuers are covered and open a security page; the rest are on file here only.